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idiopathic arthritis: a new model for EHR-based
research
Tyler S Cole1*†, Jennifer Frankovich2†, Srinivasan Iyer1, Paea LePendu1, Anna Bauer-Mehren1 and Nigam H Shah1Abstract
Background: Juvenile idiopathic arthritis is the most common rheumatic disease in children. Chronic uveitis is a
common and serious comorbid condition of juvenile idiopathic arthritis, with insidious presentation and potential
to cause blindness. Knowledge of clinical associations will improve risk stratification. Based on clinical observation,
we hypothesized that allergic conditions are associated with chronic uveitis in juvenile idiopathic arthritis patients.
Methods: This study is a retrospective cohort study using Stanford’s clinical data warehouse containing data from
Lucile Packard Children’s Hospital from 2000–2011 to analyze patient characteristics associated with chronic uveitis
in a large juvenile idiopathic arthritis cohort. Clinical notes in patients under 16 years of age were processed via a
validated text analytics pipeline. Bivariate-associated variables were used in a multivariate logistic regression adjusted
for age, gender, and race. Previously reported associations were evaluated to validate our methods. The main outcome
measure was presence of terms indicating allergy or allergy medications use overrepresented in juvenile idiopathic
arthritis patients with chronic uveitis. Residual text features were then used in unsupervised hierarchical clustering to
compare clinical text similarity between patients with and without uveitis.
Results: Previously reported associations with uveitis in juvenile idiopathic arthritis patients (earlier age at arthritis
diagnosis, oligoarticular-onset disease, antinuclear antibody status, history of psoriasis) were reproduced in our study.
Use of allergy medications and terms describing allergic conditions were independently associated with chronic uveitis.
The association with allergy drugs when adjusted for known associations remained significant (OR 2.54, 95% CI 1.22–5.4).
Conclusions: This study shows the potential of using a validated text analytics pipeline on clinical data warehouses to
examine practice-based evidence for evaluating hypotheses formed during patient care. Our study reproduces four
known associations with uveitis development in juvenile idiopathic arthritis patients, and reports a new association
between allergic conditions and chronic uveitis in juvenile idiopathic arthritis patients.
Keywords: Juvenile idiopathic arthritis, Uveitis, Allergy, Electronic health records, Text mining, Biomedical informaticsBackground
Juvenile idiopathic arthritis (JIA) is the most common
rheumatic disease in children, with prevalence rates similar
to juvenile-onset diabetes, as high as 4.01 per 1,000 children
[1]. Chronic uveitis is the most threatening co-morbid
condition seen in JIA patients and affects between 2%
and 38% of children with arthritis [2]. Untreated uveitis* Correspondence: tylcole@stanford.edu
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reproduction in any medium, provided the orcan lead to cataracts, glaucoma, band keratopathy, retinal
detachment and vision loss [3]. Most JIA patients with
uveitis have asymptomatic eye disease [4] and, due to their
young age, are unable to articulate and/or recognize the
vision changes; because of this, clinicians must screen for
uveitis routinely.
Current screening guidelines are based on the under-
standing of two risk factors, age and ANA status [5].
Such algorithms have been the backbone of curtailing
ocular complications of uveitis [2], and the discovery of
novel associations will improve risk stratification with
regular screening. The knowledge embedded in clinicald. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Cole et al. Pediatric Rheumatology 2013, 11:45 Page 2 of 9
http://www.ped-rheum.com/content/11/1/45documents from electronic health records—used, for
example, to inform therapy decisions in juvenile systemic
lupus erythematosus [6]—could enable such discovery for
JIA and uveitis.
With computational advances in processing unstructured
clinical data, large repositories of clinical data have been
used for pharmacovigilance [7], phenotypic profiling
[8], and for generating practice-based evidence [9]. With
structured billing and claims data complemented by
the rich content of clinical text, researchers argue that
much of clinical medicine can benefit from analyzing data
already in clinical data warehouses [6,7,10-17]. Investigators
can use this data to reveal associations and predictors
for hard to detect, yet severe, disease complications and
co-morbidities.
Based on clinical observations, we hypothesized that
allergic conditions may be associated with uveitis in JIA
patients and examined this association via an informatics
approach. We tested for allergy associations by mining
unstructured clinical notes and coded data. Although
the methods applied have been validated in other studies
[7,9,18-21], as an internal validation we reproduced
previously reported associations of uveitis including age
[22-26], oligoarticular-onset disease [3,22-25,27], anti-
nuclear antibody (ANA) status [22-25,27], rheumatoid
factor (RF) status [22,23,28], and the presence of psoriasis
in the patient or in immediate relatives [29]. This study
adds to a growing literature demonstrating the potential
of analyzing clinical data warehouses for rapidly evaluating
a clinically formed hypotheses using practice-based
evidence [11,30].
Methods
Data source
Our patient population was drawn from the Stanford
Translational Research Integrated Database Environment
(STRIDE), containing data from 1.8 million patients from
the Stanford Hospital and Clinics and the Lucile Packard
Children’s Hospital. Acquisition and processing of data
was approved by the Stanford Institutional Review Board.
Patient population
Patients followed by the pediatric rheumatology division
at Lucile Packard Children’s Hospital were included in
the study. The pediatric rheumatologists at our center
participate in the medical management of uveitis in
conjunction with a community and/or university oph-
thalmologist. Each clinical encounter is coded with
diagnosis codes for JIA and uveitis (if present) using a
standardized rheumatology clinic billing form. ICD-9
code standards have not changed during the study time
period. Summaries of all clinical patient encounters are
dictated by pediatric residents, rheumatology fellows, and
pediatric rheumatology attending physicians using ourclinic encounter template form which includes medication
reconciliation of both prescription and non-prescription
medications.
Cohort selection
Cohort selection was based on both ICD-9 diagnosis
codes and the contents of the processed clinical notes
relating to the diagnosis as outlined in Figure 1. A
dual-layered method of patient identification was used
to avoid the selection of incorrectly coded patients, a
common and well-documented error in the medical
literature [31-33]. The ICD-9 codes and terms used to
identify patients are shown in Table 1. Patients under
age 16 with JIA were identified between 1/1/2000 until
12/31/2011 (N = 602) and merged with patients diag-
nosed with chronic uveitis to obtain a cohort of JIA
patients with chronic uveitis and a cohort with JIA alone.
Patients with only a diagnosis of acute uveitis (ICD-9 code
364.0) were included; those with no diagnosis of chronic
uveitis (ICD-9 code 364.1) were excluded (N = 4). Since
patients without uveitis tended to have fewer notes in their
clinical records, patients with less than 25 clinical notes
were excluded to balance this variable and prevent
documentation bias. Cohort characteristics and balance
are shown in Table 2.
Clinical note processing
Textual notes were processed using an optimized version
of the NCBO Annotator [19-21] and 22 clinically relevant
ontologies. The ontologies provide a lexicon of clinical
terms, from which, using a variety of statistical and
manual filters [34-38], we removed ambiguous terms
including overly frequent or general terms, and misleading
abbreviations. We also flagged negated terms and terms
attributed to family history [39], and utilized the family
history attribution in evaluation of psoriasis as a risk
factor. The processing steps are summarized in Additional
file 1: Figure S1. We evaluated our clinical note processing
pipeline for accuracy in recognizing disease events using a
gold standard corpus [40], which has been manually
annotated by two annotators for 16 conditions. Overall,
our event identification has 74% sensitivity and 96%
specificity. Recognition of drug exposure is done in a
similar manner, and an independent study [41] estimated
over 84% recall and 84% precision for recognizing drugs.
We then used the terms in Table 1 and simple variants
of those terms, as well as matching medication names,
to determine patient-term attribution. For each patient
and term, we further ordered by the time at which a
term occurred in this patient–feature matrix.
Statistical analysis
The clinical notes of the two cohorts were compared for
significant differences in the presence of oligoarticular
Figure 1 Cohort selection process using both structured ICD-9 codes and unstructed notes annotated with text analysis. From 602 JIA
patients, 42 chronic uveitis patient were selected with ICD-9 codes confirmed with mention of uveitis terms in their clinical notes. JIA patients
with under 25 notes in the clinical database were excluded to prevent documentation bias.
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Table 1 ICD-9 codes and terms used in cohort selection and potential predictors of chronic uveitis
Primary cohort (juvenile idiopathic arthritis) Outcome of interest
(chronic uveitis)*
Reported and hypothesized patient
factors associated with uveitis
Juvenile Arthritis ICD 9 codes Uveitis ICD 9 codes Medical status terms in dictated records:
696.0, 714.0, 714.2, 714.3, 714.9, 720.2, 720.9 364.00 (acute)* Ana positive, positive ana, psoriasis, allergic, allergy,
oligoarticular, oligo-onset, pauciarticular, pauci-onset,
monoarthritis, monoarticular, rheumatoid factor positive,
rf positive
364.10 (chronic)*
Terms in dictated reports used to
confirm diagnosis of juvenile arthritis:
Terms in dictated reports used to
confirm the diagnosis of uveitis:
Examples of allergy medications
dictated in clinical records:
Juvenile idiopathic arthritis, jia, juvenile
rheumatoid arthritis, jra, psoriatic arthritis, juvenile
spondyloarthropathy, spondyloarthritis, enthesitis
related arthritis, sacroiliitis, reactive arthritisand
derivatives
Uveitis, iridocyclitis, iritis, and derivatives Nasal steroids: Flonase, Nasacort
Oral Antihistamines: Allegra, Zyrtec,
Claritin, Clarinex, Benadryl, Xyzal
Nasal antihistamines: Astelin
Leukotriene inhibitors: Singulair
Decongestant: Sudafed
*This is the convention used within our institution to differentiate between acute and chronic uveitis.
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RF status, psoriasis in patient or first degree family mem-
ber, allergy drugs, and allergy terms listed in Table 1.
Temporal restriction was put on the presence of di-
phenhydramine to be strictly prior to the first diagnosis
of uveitis in the uveitis cohort to prevent confounding
by its use to prevent reactions to biologics used to treat
uveitis. We manually reviewed the extracted annotated
terms and confirmed the presence of the terms in a
non-negated context. Drugs were re-coded into a new
variable representing the presence of any allergy drug. A
two-tailed disproportionality test (Fisher’s Exact) was
used to assess association with chronic uveitis.
All variables were then examined in a multivariate lo-
gistic regression model with stepwise variable selection.
Age at first arthritis diagnosis was highly associated
with uveitis and was included in the logistic regressionTable 2 Summary of juvenile idiopathic arthritis (JIA) cohort
Controls
JIA patients with no chr
N = 255
Race, no. (%)
Asian 23 (9)
Black 5 (2)
Other/NA 54 (21)
White 173 (68)
Gender, no. (%)
Female 166 (65)
Male 89 (35)
Age, years 10.2
Number of clinical encounter dictations 55.4
*Difference in proportions analyzed using the Fisher’s exact test.
†Difference in means analyzed with a Student’s t-test.model for adjustment. Although the cohort showed no
statistical difference in race and gender (both P > 0.7),
these variables were kept in the model for adjustment.
Cluster analysis
We then performed unsupervised hierarchical clustering
based on the entire patient clinical text content prior to
uveitis diagnosis. Terms from the clinical notes of the
chronic uveitis patients were limited to the time period
prior to the diagnosis of uveitis. The median time offset
of uveitis diagnosis from arthritis diagnosis in the uveitis
group (282 days) was determined, and used as the max-
imum time from which to extract notes in the non-uveitis
cohort. Terms identified in the clinical notes were con-
verted to medical concepts based on drug and disease
ontologies (i.e. mapping similar terms to a shared concept).
The presence or absence of each concept was codedcharacteristics
Cases
onic uveitis JIA patients with chronic uveitis
N = 42
P = 0.203*
6 (15)
2 (5)
5 (12)
29 (68)
P = 0.147*
32 (76)
10 (24)
7.2 P < 0.001†
60.9 P = 0.54†
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(Euclidian) matrix was calculated. Unsupervised hier-
archical clustering based on inter-patient distance was then
performed. Terms previously used in cohort selection,
univariate analysis, or multivariate analysis were excluded
from the cluster analysis to understand effects of residual
textual features beyond those in Figure 2.Software
All statistical analysis was performed using R version
2.15.1 [42].Results
Confirming known risk factors of uveitis
In our data, age at diagnosis in this cohort reflects the
age when patients are first seen at our hospital with the
diagnosis of JIA. Since some patients transfer their care
on referral, the mean age at diagnosis in our cohort isA
B
Figure 2 Patient factors associated with chronic uveitis in
juvenile arthritis patients, bivariate analysis and multivariate
logistic regression adjusted for age at first arthritis diagnosis,
race, and gender. A) Proportion of cohort with a given term or
concept. P-values from two-tailed Fisher’s Exact test. B) Odds ratios,
confidence intervals, and model P values for multivariate association
with uveitis.biased towards an older age. The onset of arthritis was
earlier in patients who develop uveitis (onset at 7.23 versus
10.17 years, P < 0.001). There was no significant difference
in sex between the two groups (P = 0.147), with more
females overall.
ANA positivity mentions were increased in chronic
uveitis patients (adjusted OR 5.38, 95% CI 2.48–12.45,
P < 0.001). Oligoarticular onset pattern was identified as a
risk factor (adjusted OR 3.66, 95% CI 1.71–8.25, P < 0.001)
based on data from the first 6 months after JIA diagnosis.
There was also a positive association between uveitis and
psoriasis in the patient or family member (adjusted OR
2.74, 95% CI 1.21–6.1, P = 0.03). An inverse relationship
was noted between RF positivity and uveitis (adjusted OR
0.18, 95% CI 0.01–0.96, P = 0.03).
Testing the hypothesized association between allergies
and uveitis
The concept of “allergy” is diffuse, so we examined the
hypothesis regarding association of allergy with chronic
uveitis in two ways. First, we checked for non-negated
mentions of “allergy” and “allergic” within the clinical notes.
Second, we created a list and checked for mentions of
allergy medications commonly used to treat nasal allergy
symptoms in children. We included both over-the-counter
and prescription medications, outlined in Table 1.
Allergy drugs were grouped to increase statistical power
given the large variety of allergy drugs used and the small
patient cohort size. Allergy medication documentation
was used as a proxy for nasal allergies; medication rec-
onciliation is a routine part of the medical interview in
our pediatric rheumatology clinic and is documented in
the clinic visit dictations.
With bivariate analysis, the presence of an allergy drug
showed the strongest association with chronic uveitis
(OR 2.92, 95% CI 1.47–5.91, P < 0.001). Bivariate analysis
also showed the presence of terms “allergic” (OR 2.68,
95% CI 1.34–5.55, P = 0.002) and “allergy” (OR 2.14, 95%
CI 1.08–4.27, P = 0.016) to be associated. After finding a
positive association with the allergy terms, we subsequently
evaluated sinusitis due to its association with allergies.
However, terms relating to sinusitis were not statistically
associated (OR 1.95, 95% CI 0.94–3.8, P = 0.051).
The variables shown in Figure 2A were incorporated
into a multivariate logistic regression model to assess
adjusted associations. Age at first arthritis diagnosis was
included in the model to account for residual confounding
given its strong association. The results of this analysis are
shown in Figure 2B. The presence of an allergy drug (OR
2.54, 95% CI 1.22–5.4, P = 0.01) remains associated in
the multivariate analysis. There was an overall 14%
prevalence of uveitis in our JIA cohort. With estimation
of 50% sensitivity for allergy detection and 25% sensitivity
of early uveitis detection after referral for continued
Cole et al. Pediatric Rheumatology 2013, 11:45 Page 6 of 9
http://www.ped-rheum.com/content/11/1/45ophthalmologic evaluation prior to other indications
for referral, this would represent a number needed to
screen of 95.
The terms “allergy” and “allergic” are independently
associated with uveitis (OR 2.14 and 2.68), but less strongly
as compared to allergy medications (OR 2.92). Patients
who have “allergy” or “allergic” in their clinical notes
also tend to have mentions of an allergy drug, therefore
the allergy term variable is eliminated in the multivariate
model building with stepwise variable selection. When
allergy terms are included and allergy medications are
excluded in model building, the association with allergy
terms remains significant (OR 2.3, 95% CI 1.11–4.96).
Manual verification in the 25 chronic uveitis patients
with identified allergy drug mentions confirmed direct
mentions of allergy conditions in 20 patients. In 3 patients,
allergic symptoms and/or consultation with an allergist
were directly mentioned. In 2 patients’ clinical text, only
direct mention of the allergy drug was identified. Given
mandatory medication reconciliation during clinic visits at
our institution, and potentially unreliable documentation
of allergic conditions such as seasonal allergies due to
their high prevalence, mentions of allergy drugs may
be a more reliable indicator of allergic conditions.
Rheumatologists, ophthalmologists, and pediatricians
at our institution do not prescribe the allergy medications
identified in our study for general anti-inflammatory
purposes.Cluster analysis indicating presence of additional
associations with uveitis
As a qualitative look into the potential of such analytics
on clinical data warehouses to discover additional factors
associated with chronic uveitis, we clustered our cohort
of patients based on the terms in their clinical record
blinded to a future diagnosis of uveitis (Figure 3). In order
to investigate if residual associations within the clinical
record were strong enough to cluster patients prior to
uveitis diagnosis, terms relating to RF status, ANA status,
oligoarticular subtype, psoriasis, and allergy were excluded,
as were demographic variables and terms already used in
cohort selection.
We find that the patients who ultimately develop uveitis
do tend to cluster together—even after the exclusion of
the strongly associated variables that were the focus of
this study—indicating that there are additional predictors
within clinical documentation to be investigated. 20 uveitis
patients form the main cluster, with only 3 non-uveitis
patients included. Influential features of clinical interest
include mentions of medications such as beclomethasone,
commonly used in pediatric asthma and nasal allergies,
and mentions of conditions such as contact dermatitis,
folliculitis, and hypersensitivity (P < 0.02).Discussion
We examined a hypothesis of a possible association
between allergic conditions and uveitis in JIA patients
by querying a clinical data warehouse. To validate our
methods in the current use case, we demonstrated known
positive and negative associations with uveitis in JIA. The
onset of arthritis has been demonstrated to be earlier in
patients who develop uveitis [26], as shown in the current
study. The established associations between uveitis and
positive ANA status [22-25], oligoarticular onset pattern
of JIA [3,22-25,27], and psoriasis (in patient or first degree
family member) [29] is supported by our data. An inverse
relationship has been established between RF positivity
and uveitis [22,23,28], also confirmed in our study. The
ability to also identify negative associations helps to
provide an internal validation of the study approach.
After confirming these associations, we present evidence
supporting a clinically formed hypothesis about an associ-
ation between allergic conditions and uveitis. This study
highlights the potential of text analytics on unstructured
data in clinical data warehouses to examine hypotheses
formed during clinical care using practice-based evidence.
Without such a computational approach, such hypotheses
might be impractical to answer using traditional chart
review studies.
We argue that data-mining of electronic medical re-
cords—which researchers currently use to inform therapy
decisions [6] and enable phase IV surveillance [9,18,19]—
should be extended to learn associations and predictors of
hard to detect, yet severe, disease complications. Taking
such an approach also allows a spectrum of variables to
be assessed. Understudied subgroups such as children,
the elderly, underrepresented ethnic groups, and pregnant
women can be investigated with this approach.
Despite the efficacy of such text-based analyses demon-
strated in pharmacovigilance, off-label drug use, and in
studying chronic conditions [7,9,18-21], this study has
several potential limitations that warrant discussion.
Although text analysis techniques achieve 97% accuracy
in detecting negated terms, 93% accuracy in detecting
drug mentions, and 86% accuracy in recognizing disease
conditions in validation studies [7,9,19,20], events occur-
ring outside of the hospital can lead to false negatives.
Additionally, it is possible that there is increased reporting
of allergic conditions and allergy medications among the
chronic uveitis sub-group due to a higher level of concern
given the eye disease complication. For these reasons,
we feel that a prospective study must validate our findings
before allergic conditions can be used as a clinically useful
predictor.
In order to account for under-reporting bias arising
from fewer visits in patients with less co-morbidity (i.e.,
the non-uveitis cohort), cases and controls were matched
on the number of clinical dictations. The unbalanced JIA
AB
C
Figure 3 Phylogram clustering of patients with juvenile arthritis based on residual features in the clinical record prior to uveitis
diagnosis. A) Timeline showing the source of clinical notes in chronic uveitis patients and B) non-uveitis patients. C) Plot of hierarchical clustering
based on the similarity of patient note content. Red represents uveitis patients and blue represents non-uveitis patients.
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number of notes as the cohort with uveitis, and initial
analysis including patients with fewer notes revealed
stronger positive associations in the uveitis cohort. This
was interpreted as falsely strong associations since we
could not ensure that patients with less clinical record
content were truly negative for a given factor or negative
due to less thorough documentation. However, it is
possible that patients with fewer notes have less severe
disease, biasing the study population to those patients
with more severe JIA. This tradeoff to ensure similar
medical record information content must be recognized.
Finally, this study does not address causation. Indeed,
the association between allergy and uveitis is unantici-
pated since autoimmune disorders are thought to have a
Th1/Th17 bias while allergic disorders tend to be associ-
ated with a Th2 cytokine profile. However, this immune
classification may be an oversimplification in patients
with complex and overlapping diseases, such as those
with both uveitis and JIA. Recent investigation suggests
that Th2 cytokines in the anterior chamber of the eye
distinguish patients with idiopathic uveitis from controls
using cluster analysis methods [43]. Furthermore, we
argue that allergies may be a surrogate risk factor possibly
reflecting a heightened immune response to antigens in
certain tissues, or a predisposition to both symptomatic
and asymptomatic sinusitis where associated bacterial
antigens may be the driver of an immune reaction.If this type of research is performed widely and reli-
ably, then it will become a key aspect of meaningfully
using electronic medical records, summarizing practice-
based evidence, and can help prioritize prospective
clinical trials [6,11,30].
Conclusion
We report an association between allergic conditions
and chronic uveitis in JIA patients. We uncovered this
association via analyzing the clinical notes using a validated
text analytics data-mining pipeline. If the association is
confirmed in prospective studies, it may inform pathogenic
mechanisms and help guide clinicians in uveitis screening
in patients with allergic conditions. This study shows
the potential of analyzing clinical data warehouses to gain
new clinical insights and to rapidly prioritize hypotheses
formed during clinical care using practice-based evidence.
Additional file
Additional file 1: Figure S1. Generation of the patient–feature matrix.
This process (1) starts by downloading ~5.6 M strings for every term in
ontologies from both UMLS and BioPortal as well as all trigger terms
from NegEx and ConText, (2) uses term frequency and syntactic type
information (e.g., predominant noun phrases) from MedLine to prune the
set of strings into a clean lexicon, (3) applies the lexicon directly against
the textual notes using exact string matching, (4) applies NegEx and
ConText rules to identify negated terms and family history contexts
respectively, (5) applies UMLS and BioPortal mappings and semantic type
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disease, device, or procedure, (6) and results finally in the patient–feature
matrix. Each row of the matrix represents a single patient’s note and the
timestamps of the notes induces a temporal ordering over the entire
patient–feature matrix.
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